环庚烯-1-基硼酸 | 835882-35-4

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 硼酸衍生物
• 中文名称: 环庚烯-1-基硼酸
• 中文别名: 环庚烯-1-硼酸；1-环庚烯基-1-硼酸
• 英文名称: 1-cycloheptenyl boronic acid
• 英文别名: cycloheptenylboronic acid；Cyclohepten-1-ylboronic acid
• CAS: 835882-35-4
• 化学式: C₇H₁₃BO₂
• mdl: MFCD04115655
• 分子量: 139.99
• InChiKey: MMOVERLKAAQVGD-UHFFFAOYSA-N

物化性质

• 熔点：
  110-116°C
• 沸点：
  278.1±33.0 °C(Predicted)
• 密度：
  1.02±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.36
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2931900090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Cyclohepten-1-ylboronic acid
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Cyclohepten-1-ylboronic acid
Ingredient name:
CAS number: 835882-35-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H13BO2
Molecular weight: 140.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  环庚烯-1-基硼酸 在 吡啶 、 氧气 、 copper diacetate 、 溶剂黄146 、 sodium sulfate 作用下， 以 乙腈 为溶剂， 反应 10.0h， 生成 7,8,9,10-tetrahydrocyclohepta[b]indol-6(5H)-one
  参考文献：
  名称：

  铜催化的烯基硼酸的三或四官能度制备四氢咔唑-1-酮和吲哚[2,3-a]咔唑

  摘要：

  我们描述了烯基硼酸的三或四官能化的级联策略，以制备具有N的高收率的各种四氢咔唑-1-酮和吲哚[2,3- a ]咔唑-羟基苯并三嗪-4-酮（HOOBT）和芳基肼分别作为氧和氮源。机理研究表明，多米诺反应在一锅法反应中经过五个步骤，经历了铜催化的Chan-Lam反应，[2,3]重排，亲核取代，氧化和顺序[3,3]重排。该反应显示出广泛的底物范围，并且可以耐受多种官能团。更重要的是，该反应易于以克为单位进行，并且产物可以通过简单的萃取，洗涤和重结晶进行纯化，而无需快速柱色谱。本协议的特点是易于获得的起始原料，高位标记的功能化，一锅中的五步串联，多个C–C / C–O / C–N键形成以及吲哚图案的多样性。

  DOI：

  10.1039/d0gc01514h
• 作为产物：
  描述：

  环庚酮 在 sodium periodate 、 正丁基锂 、 四甲基乙二胺 、 ammonium acetate 、 水 作用下， 以 甲醇 、 正己烷 、 丙酮 为溶剂， 反应 5.0h， 生成 环庚烯-1-基硼酸
  参考文献：
  名称：

  铜催化的烯基硼酸的三或四官能度制备四氢咔唑-1-酮和吲哚[2,3-a]咔唑

  摘要：

  我们描述了烯基硼酸的三或四官能化的级联策略，以制备具有N的高收率的各种四氢咔唑-1-酮和吲哚[2,3- a ]咔唑-羟基苯并三嗪-4-酮（HOOBT）和芳基肼分别作为氧和氮源。机理研究表明，多米诺反应在一锅法反应中经过五个步骤，经历了铜催化的Chan-Lam反应，[2,3]重排，亲核取代，氧化和顺序[3,3]重排。该反应显示出广泛的底物范围，并且可以耐受多种官能团。更重要的是，该反应易于以克为单位进行，并且产物可以通过简单的萃取，洗涤和重结晶进行纯化，而无需快速柱色谱。本协议的特点是易于获得的起始原料，高位标记的功能化，一锅中的五步串联，多个C–C / C–O / C–N键形成以及吲哚图案的多样性。

  DOI：

  10.1039/d0gc01514h

文献信息

• Interrupted Fischer-Indole Intermediates via Oxyarylation of Alkenyl Boronic Acids
  作者：Heng-Yen Wang、Laura L. Anderson

  DOI：10.1021/ol401416r

  日期：2013.7.5

  The oxyarylation of alkenyl boronic acids with N-arylbenzhydroxamic acids has been achieved under both copper-mediated and copper-catalyzed conditions to provide access to interrupted Fischer-indole intermediates. This transformation is believed to proceed through a copper-promoted C–O bond forming event followed by a [3,3] rearrangement. The scope of the method is described and mechanistic experiments

  在铜介导的和铜催化的条件下，已经实现了烯基硼酸与N-芳基苯并异羟肟酸的氧化芳基化，以提供接近的费歇尔-吲哚中间体的途径。据认为，这种转变是通过铜促进的C–O键形成事件继之以[3,3]重排而进行的。描述了该方法的范围并讨论了机械实验。
• INHIBITORS OF C-FMS KINASE
  申请人：Illig Carl R.

  公开号：US20070249593A1

  公开（公告）日：2007-10-25

  The invention is directed to compounds of Formula I: wherein Z, X, J, R 2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

  本发明涉及式I化合物：其中Z、X、J、R2和W在说明书中规定，以及抑制蛋白酪氨酸激酶，尤其是c-fms激酶的溶剂化物、水合物、互变异构体和药用盐。治疗自身免疫病；和治疗具有炎症成分的疾病；治疗来自卵巢癌、子宫癌、乳腺癌、前列腺癌、肺癌、结肠癌、胃癌、毛细胞白血病的转移；和治疗疼痛，包括由肿瘤转移或骨关节炎引起的骨骼疼痛，或内脏、炎症性和神经性疼痛；以及骨质疏松症、佩吉特病，以及骨吸收介导病状的其它疾病，包括类风湿性关节炎、其它形式的炎症性关节炎、骨关节炎、假体失败、溶骨肉瘤、骨髓瘤和骨转移瘤，也提供了式I化合物。
• Preparation and Rearrangement of <i>N</i>-Vinyl Nitrones: Synthesis of Spiroisoxazolines and Fluorene-Tethered Isoxazoles
  作者：Dong-Liang Mo、Donald A. Wink、Laura L. Anderson

  DOI：10.1021/ol3022885

  日期：2012.10.19

  N-Vinyl nitrones derived from fluorenone have been prepared via a copper-mediated coupling between fluorenone oxime and vinyl boronic acids. These compounds undergo subsequent rearrangement and addition reactions that are distinct from the traditional [3 + 2] cycloaddition reactivity of nitrones. Thermal rearrangements of fluorenone N-vinyl nitrones give spiroisoxazolines, while treatment with alkynes

  经由芴酮肟和乙烯基硼酸之间的铜介导的偶联，制备了衍生自芴酮的N-乙烯基硝酮。这些化合物会经历随后的重排和加成反应，这不同于传统的硝酮的[3 + 2]环加成反应性。芴酮N-乙烯基硝酮的热重排生成螺异恶唑啉，而用炔烃处理则得到芴系的异恶唑。讨论了芴酮N-乙烯基硝酮的制备及其局限性及其后续的重排和加成反应。
• Diastereoselective Synthesis of Nine-Membered Heterocycles <i>via</i> the Cycloaddition and Sequential Rearrangement of <i>N</i> -Vinyl Nitrones with Isocyanates
  作者：Ning Zou、Ji-Wen Jiao、Yu Feng、Chun-Hua Chen、Cui Liang、Gui-Fa Su、Dong-Liang Mo

  DOI：10.1002/adsc.201700685

  日期：2017.10.25

  A metal‐free construction of highly diastereoselective nine‐membered heterocycles is described via the cycloaddition and rearrangement of N‐vinyl‐α,β‐unsaturated ketonitrones and isocyanates. Notably, the prepared nine‐membered heterocycles afforded 2,3‐dihydropyrrolizines under heating conditions. Mechanistic studies showed that the nine‐membered rings might undergo decarboxylation, isomerization

  通过N-乙烯基-α，β-不饱和酮硝酮和异氰酸酯的环加成和重排描述了高度非对映选择性的九元杂环的无金属结构。值得注意的是，在加热条件下，所制备的九元杂环提供了2,3-二氢吡咯烷酮。机理研究表明，九元环可能会发生脱羧，异构化，氮杂-迈克尔加成和芳构化，从而在一锅反应中得到2,3-二氢吡咯啉。
• Iron(<scp>iii</scp>)-catalyzed selective N–O bond cleavage to prepare tetrasubstituted pyridines and 3,5-disubstituted isoxazolines from <i>N</i>-vinyl-α,β-unsaturated ketonitrones
  作者：Chun-Hua Chen、Qing-Yan Wu、Cui Wei、Cui Liang、Gui-Fa Su、Dong-Liang Mo

  DOI：10.1039/c8gc00630j

  日期：——

  An iron(III)-catalyst controlled cyclization and selective N–O bond cleavage of N-vinyl-α,β-unsaturated nitrones has been achieved under mild conditions to access tetrasubstituted pyridines and 3,5-disubstituted isoxazolines in moderate to good yields. The tetrasubstituted pyridines were afforded with FeCl3 as a catalyst while using FeCl3·6H2O combined with 1,10-phenanthroline delivered isoxazolines

  在温和的条件下，以中等至良好的产率获得四取代吡啶和3,5-二取代异恶唑啉，已实现铁（III）催化剂控制的环化和N-乙烯基-α，β-不饱和硝酮的选择性N–O键裂解。用FeCl 3作为催化剂提供四取代的吡啶，同时使用FeCl 3 ·6H 2 O与1,10-菲咯啉传递的异恶唑啉组合。N中苯乙烯基环化的区域选择性吡啶和异恶唑啉的形成过程中，-乙烯基-α，β-不饱和硝酮完全不同。在进一步的对照实验研究的基础上，提出了形成吡啶和异恶唑啉的合理机理。当将乙酸铜（II）与制备的双齿N-配体结合使用时，可将异恶唑啉经四个步骤转化为新的双齿N-配体，并且从N-乙烯基硝酮获得环氧吡啶骨架。